Molecular epidemiology of imipenem-resistant Acinetobacter haemolyticus and Acinetobacter baumannii isolates carrying plasmid-mediated OXA-40 from a Portuguese hospital.
作者信息
Quinteira Sandra, Grosso Filipa, Ramos Helena, Peixe Luísa
出版信息
Antimicrob Agents Chemother. 2007 Sep;51(9):3465-6. doi: 10.1128/AAC.00267-07. Epub 2007 Jul 2.
Abstract
摘要
相似文献
1
Molecular epidemiology of imipenem-resistant Acinetobacter haemolyticus and Acinetobacter baumannii isolates carrying plasmid-mediated OXA-40 from a Portuguese hospital.
Antimicrob Agents Chemother. 2007 Sep;51(9):3465-6. doi: 10.1128/AAC.00267-07. Epub 2007 Jul 2.
2
Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
J Microbiol Immunol Infect. 2012 Feb;45(1):43-51. doi: 10.1016/j.jmii.2011.09.020. Epub 2011 Dec 14.
3
A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58.
J Antimicrob Chemother. 2005 Jan;55(1):115-8. doi: 10.1093/jac/dkh500. Epub 2004 Dec 8.
4
Long-term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula.
J Antimicrob Chemother. 2004 Jul;54(1):255-8. doi: 10.1093/jac/dkh269. Epub 2004 Jun 9.
5
Understanding the dynamics of imipenem-resistant Acinetobacter baumannii lineages within Portugal.
Clin Microbiol Infect. 2011 Aug;17(8):1275-9. doi: 10.1111/j.1469-0691.2011.03469.x. Epub 2011 Mar 7.
6
Nosocomial spread of OXA-58-positive carbapenem-resistant Acinetobacter baumannii isolates in a paediatric hospital in Greece.
Clin Microbiol Infect. 2006 Nov;12(11):1138-41. doi: 10.1111/j.1469-0691.2006.01537.x.
7
Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit.
Clin Microbiol Infect. 2008 Jun;14(6):588-94. doi: 10.1111/j.1469-0691.2008.01996.x. Epub 2008 Apr 5.
8
Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals.
Jpn J Infect Dis. 2008 Jul;61(4):274-8.
9
Dissemination of multidrug-resistant Acinetobacter baumannii genotypes carrying bla(OXA-23) collected from hospitals in Rio de Janeiro, Brazil.
Int J Antimicrob Agents. 2009 Jul;34(1):25-8. doi: 10.1016/j.ijantimicag.2008.12.009. Epub 2009 Feb 11.
10
Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland.
Clin Microbiol Infect. 2007 May;13(5):490-6. doi: 10.1111/j.1469-0691.2007.01694.x. Epub 2007 Feb 28.
引用本文的文献
1
Tackling Carbapenem Resistance and the Imperative for One Health Strategies-Insights from the Portuguese Perspective.
Antibiotics (Basel). 2024 Jun 14;13(6):557. doi: 10.3390/antibiotics13060557.
2
Molecular epidemiology of carbapenem-resistant isolates in Turkiye: Systematic review.
North Clin Istanb. 2023 Aug 4;10(4):531-539. doi: 10.14744/nci.2022.17003. eCollection 2023.
3
Distribution of Carbapenemase Genes among Carbapenem-Non-Susceptible Blood Isolates in Indonesia: A Multicenter Study.
Antibiotics (Basel). 2022 Mar 9;11(3):366. doi: 10.3390/antibiotics11030366.
4
The carbapenem resistance gene bla is disseminated by a conjugative plasmid containing the novel transposon Tn6681 in Acinetobacter johnsonii M19.
Antimicrob Resist Infect Control. 2020 Nov 9;9(1):182. doi: 10.1186/s13756-020-00832-4.
5
First report of OXA-143-lactamase producing in Qom, Iran.
Iran J Basic Med Sci. 2017 Nov;20(11):1282-1286. doi: 10.22038/IJBMS.2017.9490.
6
Biology of : Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options.
Front Cell Infect Microbiol. 2017 Mar 13;7:55. doi: 10.3389/fcimb.2017.00055. eCollection 2017.
7
Insights on the Horizontal Gene Transfer of Carbapenemase Determinants in the Opportunistic Pathogen Acinetobacter baumannii.
Microorganisms. 2016 Aug 23;4(3):29. doi: 10.3390/microorganisms4030029.
8
Risk factors for infection with colistin-resistant gram-negative microorganisms: a multicenter study.
Ann Saudi Med. 2016 May-Jun;36(3):216-22. doi: 10.5144/0256-4947.2016.216.
9
Acquired Class D β-Lactamases.
Antibiotics (Basel). 2014 Aug 21;3(3):398-434. doi: 10.3390/antibiotics3030398.
10
Urban riverine environment is a source of multidrug-resistant and ESBL-producing clinically important Acinetobacter spp.
Environ Sci Pollut Res Int. 2016 Feb;23(4):3525-35. doi: 10.1007/s11356-015-5586-0. Epub 2015 Oct 21.
本文引用的文献
1
Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England.
J Clin Microbiol. 2006 Oct;44(10):3623-7. doi: 10.1128/JCM.00699-06.
2
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
Clin Microbiol Infect. 2006 Sep;12(9):826-36. doi: 10.1111/j.1469-0691.2006.01456.x.
3
Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods.
J Clin Microbiol. 2005 Feb;43(2):925-7. doi: 10.1128/JCM.43.2.925-927.2005.
4
Long-term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula.
J Antimicrob Chemother. 2004 Jul;54(1):255-8. doi: 10.1093/jac/dkh269. Epub 2004 Jun 9.
5
Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii.
Antimicrob Agents Chemother. 2003 Jan;47(1):268-73. doi: 10.1128/AAC.47.1.268-273.2003.
6
Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain.
J Clin Microbiol. 2002 Dec;40(12):4741-3. doi: 10.1128/JCM.40.12.4741-4743.2002.
7
Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from northern Spain.
J Med Microbiol. 2001 Jan;50(1):71-77. doi: 10.1099/0022-1317-50-1-71.
8
Worldwide emergence of carbapenem-resistant Acinetobacter spp.
J Antimicrob Chemother. 1998 May;41(5):576-7. doi: 10.1093/jac/41.5.576.
9
Activities of beta-lactams against Acinetobacter genospecies as determined by agar dilution and E-test MIC methods.
Antimicrob Agents Chemother. 1997 Apr;41(4):767-70. doi: 10.1128/AAC.41.4.767.
10
A reassessment of the in-vitro activity of colistin sulphomethate sodium.
J Antimicrob Chemother. 1997 Feb;39(2):255-60. doi: 10.1093/jac/39.2.255.
Zotero 插件